1999
DOI: 10.1021/ja990441m
|View full text |Cite
|
Sign up to set email alerts
|

Protein Multilayer Formation on Colloids through a Stepwise Self-Assembly Technique

Abstract: Multilayer films of the proteins fluorescein isothiocyanate-labeled bovine serum albumin (FITC-BSA) and immunoglobulin G (IgG) were assembled on 640 nm diameter polystyrene (PS) latex particles by their alternate deposition with either positively or negatively charged polyelectrolytes. The proteins and polyelectrolytes were deposited under conditions where they were oppositely charged to one another, thereby facilitating growth of the films through electrostatic interactions. The regular, controlled, stepwise … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

13
309
0
2

Year Published

2000
2000
2013
2013

Publication Types

Select...
8
2

Relationship

2
8

Authors

Journals

citations
Cited by 415 publications
(325 citation statements)
references
References 55 publications
13
309
0
2
Order By: Relevance
“…Nano-and micro-encapsulation via LbL self-assembly has potential applications in biochemistry, pharmaceutics, controlled release, cosmetic, and catalyst [4][5][6]. The first approach directly used proteins, for instance, as the depositing species to prepare bioactive core-shell particles [17][18][19]. The second approach involved direct coverage of drug microcrystals, such as ibuprofen (IBU) [20,21], furosemide [22], vitamin K 3 [23], insulin [23], dexamethasone [24,25], and indomethacin [26][27][28] with polyelectrolyte multilayer films for prolonged release.…”
Section: Introductionmentioning
confidence: 99%
“…Nano-and micro-encapsulation via LbL self-assembly has potential applications in biochemistry, pharmaceutics, controlled release, cosmetic, and catalyst [4][5][6]. The first approach directly used proteins, for instance, as the depositing species to prepare bioactive core-shell particles [17][18][19]. The second approach involved direct coverage of drug microcrystals, such as ibuprofen (IBU) [20,21], furosemide [22], vitamin K 3 [23], insulin [23], dexamethasone [24,25], and indomethacin [26][27][28] with polyelectrolyte multilayer films for prolonged release.…”
Section: Introductionmentioning
confidence: 99%
“…3,7,18,19,[21][22][23][24] The mild aqueous conditions for encapsulating molecules into multilayer films preserves the bioactivity of fragile biomolecules such as proteins and nucleic acids. 21,22,25 By employing degradable polyelectrolytes as building blocks, the ability to tune the degradation kinetics of multilayer assemblies has been demonstrated and used to control the release kinetics of compounds embedded in these films. 20,26 Applications envisioned for such drug-loaded films include antimicrobial-or anti-inflammatory coatings on implants and drug-releasing coatings for stents.…”
mentioning
confidence: 99%
“…The location of these functional units (which may be small molecules, pendants on the polyelectrolyte chains, or particles) within the multilayer stack can be controlled with subnanometer precision. A wide variety of functionalities have been demonstrated, including organic molecules (He et al, 2000a), synthetic polymers , biopolymers (Burke and Barrett, 2003b), natural proteins (Caruso and Mo¨hwald, 1999), colloids (Lvov et al, 1997), inorganic nanoparticles (Kotov et al, 1995), clay platelets (Kleinfeld and Ferguson, 1994) (used as a nacre biomimic [Tang et al, 2003]), dendrimers (Watanabe and Regen, 1994), electrochemically active species (Knoll, 1996), functionalized C 60 (Mattoussi et al, 2000), and even, counterintuitively, uncharged and nonpolar polymer chains (Rouse and Ferguson, 2002). Many research groups have investigated the possibility of incorporating optically responsive azobenzene chromophores into the versatile PEM structures (examples presented in Fig.…”
Section: Polyelectrolyte Multilayersmentioning
confidence: 99%